- List
- By Topic
- On Map
- Search Details

Darunavir OR Prezista[TREATMENT] AND HIV [CONDITION]
Need help? See RSS Feeds
Choose a feed type:

Darunavir OR Prezista[TREATMENT] AND HIV [CONDITION] (225 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT03101644 | Recruiting | Optimization of Darunavir Therapy and Dosage Recommendations |
|
|
Interventional | Phase 4 |
|
Other |
|
|
150 | All | 18 Years and older (Adult, Senior) | NCT03101644 | UCL-LB-02 | March 23, 2017 | September 2018 | September 2018 | April 5, 2017 | April 26, 2017 |
|
||
2 | NCT02384967 | Completed | Evaluation of a Dose Reduction of Darunavir (400 mg/d) in Virologically Suppressed HIV-1 Patients |
|
|
Interventional | Phase 2 |
|
Other |
|
|
100 | All | 18 Years and older (Adult, Senior) | NCT02384967 | ANRS 165 DARULIGHT | DARULIGHT | March 2015 | October 2016 | October 2016 | March 10, 2015 | January 24, 2017 |
|
|
3 | NCT02671383 | Recruiting | Evaluation of Low-dose Darunavir in a Switch Study |
|
|
Interventional | Phase 3 |
|
Other |
|
|
300 | All | 18 Years to 100 Years (Adult, Senior) | NCT02671383 | WRHI052 | DRV | July 2016 | September 2017 | September 2017 | February 2, 2016 | July 12, 2016 |
|
|
4 | NCT01606722 | Completed | Darunavir Levels, Virological Efficacy, Proviral ADN and Resistances in Patients on Darunavir/Ritonavir Monotherapy |
|
|
Observational |
|
Other |
|
|
150 | All | 18 Years to 65 Years (Adult) | NCT01606722 | LLC-DAR-2010-01 | MonDar | January 2010 | June 2013 | June 2013 | May 28, 2012 | July 11, 2013 |
|
||
5 | NCT02503462 | Terminated | Effect of Cobicistat Versus Ritonavir Boosting on the Brain Permeation of Darunavir in HIV-infected Individuals |
|
|
Interventional | Phase 4 |
|
Other |
|
|
7 | All | 18 Years and older (Adult, Senior) | NCT02503462 | DRVCOBI | July 2015 | January 2017 | January 2017 | July 21, 2015 | February 2, 2017 |
|
||
6 | NCT03123848 | Completed | A Study to Evaluate the Pharmacokinetics (PK) of Darunavir (DRV) and Cobicistat (COBI) After a Single Oral Administration of Darunavir/Cobicistat Fixed-Dose Combination in Healthy Japanese Adult Participants |
|
|
Interventional | Phase 4 |
|
Industry |
|
|
8 | All | 20 Years to 55 Years (Adult) | NCT03123848 | CR108319 TMC114FD1HTX4002 |
April 14, 2017 | May 19, 2017 | May 19, 2017 | April 21, 2017 | June 19, 2017 |
|
||
7 | NCT02404233 | Unknown † | Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
30 | All | 18 Years to 70 Years (Adult, Senior) | NCT02404233 | TMC278HIV4003 | PREZENT | March 2015 | September 2016 | December 2016 | March 31, 2015 | March 31, 2015 |
|
|
8 | NCT02159599 | Completed | Study to Evaluate Darunavir/Ritonavir + Lamivudine Versus Continuing With Darunavir/Ritonavir + Tenofovir/Emtricitabine or Abacavir/Lamivudine in HIV Infected Subject |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
249 | All | 18 Years and older (Adult, Senior) | NCT02159599 | GESIDA 8014 2014-000515-14 |
DUAL | July 2014 | April 2016 | April 2016 | June 10, 2014 | February 14, 2017 |
|
|
9 | NCT01375881 | Completed | Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice |
|
|
Observational |
|
Industry |
|
|
31 | All | 18 Years and older (Adult, Senior) | NCT01375881 | CR017641 TMC114HIV4042 |
June 2009 | December 2012 | December 2012 | June 17, 2011 | May 6, 2013 | ||||
10 | NCT01047995 | Completed | Pharmacokinetics (PK) Study of Once Daily Darunavir/Ritonavir and Twice and Once Daily Raltegravir in HIV-infected Subjects |
|
|
Interventional | Phase 1 |
|
Other |
|
|
26 | All | 18 Years to 65 Years (Adult) | NCT01047995 | SSAT 031 2008-008321-30 |
June 2009 | December 2009 | December 2009 | January 13, 2010 | January 13, 2010 |
|
||
11 | NCT00885495 | Unknown † | Darunavir/Ritonavir and Rosuvastatin Pharmacokinetic Study |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
12 | All | 18 Years and older (Adult, Senior) | NCT00885495 | IDC 40 | January 2009 | June 2009 | August 2009 | April 22, 2009 | April 22, 2009 |
|
||
12 | NCT00855088 | Completed | Study in Healthy Males to Measure Darunavir and Etravirine in Blood, Seminal Fluid, and Rectal Tissue |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
13 | Male | 18 Years to 49 Years (Adult) | NCT00855088 | UNC IRB 08-0419 | DESeRT | July 2009 | February 2010 | February 2011 | March 4, 2009 | May 13, 2011 |
|
|
13 | NCT01541085 | Completed | An Immunologic Study of Treatment-Naive HIV Patients Starting a Darunavir/Ritonavir- or Efavirenz-Based HAART |
|
|
Observational |
|
Industry |
|
|
33 | All | 30 Years to 50 Years (Adult) | NCT01541085 | CR017920 TMC114HIV0010 |
December 2011 | June 2013 | June 2013 | February 29, 2012 | November 26, 2013 | ||||
14 | NCT02199613 | Completed | Elvitegravir/Cobicistat/Tenofovir DF/Emtricitabine With Darunavir Treatment Simplification Strategy |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
10 | All | 19 Years and older (Adult, Senior) | NCT02199613 | H14-00490 | QuaDar | October 2014 | February 14, 2017 | February 14, 2017 | July 24, 2014 | November 6, 2017 |
|
|
15 | NCT01869634 | Completed | Mechanisms of Immune Reconstitution & Reduced Immune Activation Following Darunavir-based ART |
|
|
Interventional | Phase 4 |
|
Other |
|
|
37 | All | 21 Years and older (Adult, Senior) | NCT01869634 | 394080 IIS RFA _Asmuth:TMC114HIV2029 |
June 2013 | December 2016 | December 2016 | June 5, 2013 | May 30, 2017 |
|
||
16 | NCT01695954 | Unknown † | Pharmacokinetic Study of Pitavastatin and Ritonavir-Boosted Darunavir or Efavirenz |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
28 | All | 18 Years to 60 Years (Adult) | NCT01695954 | NYU 11-01787 | May 2012 | October 2012 | October 2012 | September 28, 2012 | September 28, 2012 |
|
||
17 | NCT02818348 | Completed | Clinical Trial to Evaluate Drug-drug Interactions Between Darunavir/Cobicistat and Etravirine in Hiv- Infected Patients |
|
|
Interventional | Phase 1 |
|
Other |
|
|
30 | All | 18 Years to 64 Years (Adult) | NCT02818348 | DRV/c-ETR | June 2016 | October 2016 | November 23, 2016 | June 29, 2016 | March 12, 2018 |
|
||
18 | NCT01741831 | Completed | A Post Marketing Survey Study to Evaluate the Safety and Effectiveness of Prezista |
|
|
Observational |
|
Industry |
|
|
225 | All | 18 Years and older (Adult, Senior) | NCT01741831 | CR100805 TMC114HIV4074 Prezista PMS DRV-C-11-KR-001-V06 |
July 2012 | October 2016 | October 2016 | December 5, 2012 | December 5, 2016 |
|
|||
19 | NCT02499978 | Withdrawn | Darunavir/Cobicistat and Dolutegravir to Maintain Virologic Suppression and Reduce NRTI-associated Toxicity |
|
|
Interventional | Phase 2 Phase 3 |
|
Other / Industry |
|
|
0 | All | 18 Years and older (Adult, Senior) | NCT02499978 | deNUC | TMC114HIV2030 | May 2016 | June 2016 | June 2016 | July 16, 2015 | October 31, 2016 |
|
|
20 | NCT02337322 | Recruiting | Immune Recovery in Advanced , ARV-naïve, HIV-1-infected Individuals Taking Dolutegravir or Ritonavir-boosted Darunavir |
|
|
Interventional | Phase 4 |
|
Other |
|
|
108 | All | 18 Years and older (Adult, Senior) | NCT02337322 | Advanz-4 | March 31, 2015 | December 2019 | December 2019 | January 13, 2015 | April 13, 2018 |
|
||
21 | NCT01423812 | Completed Has Results |
DRIVESHAFT: Darunavir/Ritonavir In HIV-infected Virologically-suppressed Experienced Subjects |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
60 | All | 18 Years and older (Adult, Senior) | NCT01423812 | TMC114HIV4063 | DRIVESHAFT | January 2012 | May 2014 | April 2015 | August 26, 2011 | February 7, 2018 | February 7, 2018 |
|
22 | NCT01367210 | Terminated | Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA) |
|
|
Interventional | Phase 4 |
|
Other |
|
|
165 | All | 18 Years and older (Adult, Senior) | NCT01367210 | 2010-023316-13 | GUSTA | June 2011 | June 2015 | June 2015 | June 7, 2011 | February 8, 2016 |
|
|
23 | NCT03094507 | Active, not recruiting | The Pharmacokinetics of Dolutegravir, Darunavir/Cobocistat When Co-administered in Healthy Volunteers |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
20 | All | 18 Years to 65 Years (Adult) | NCT03094507 | SSAT073 | SSAT073 | April 19, 2017 | April 2018 | August 2018 | March 29, 2017 | October 31, 2017 |
|
|
24 | NCT01046890 | Completed | Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir |
|
|
Interventional | Phase 4 |
|
Other |
|
|
15 | All | 18 Years and older (Adult, Senior) | NCT01046890 | EQUIDAR | January 2010 | March 2010 | April 2010 | January 12, 2010 | May 5, 2010 |
|
||
25 | NCT01736761 | Completed | A Phase IV, Open-label Single-arm Study Investigating the Pharmacokinetics and Pharmacodynamics of the Antiretroviral Combination of Rilpivirine and Ritonavirboosted Darunavir in Therapy-naive HIV-1 Infected Patients. |
|
|
Interventional | Phase 4 |
|
Other |
|
|
36 | All | 18 Years to 65 Years (Adult) | NCT01736761 | SSAT 049 | December 2012 | March 2015 | March 2015 | November 29, 2012 | June 16, 2017 |
|
||
26 | NCT01294761 | Completed | Comparing Continuing Tenofovir, Emtricitabine (or Lamivudine) Plus Lopinavir and Switching to Raltegravir Plus Darunavir |
|
|
Interventional | Not Applicable |
|
Other |
|
|
59 | All | 20 Years and older (Adult, Senior) | NCT01294761 | FWA00005823-SPARE2011 UMIN000005116 |
SPARE | February 2011 | February 2012 | December 2013 | February 11, 2011 | March 30, 2015 |
|
|
27 | NCT02589158 | Completed | SSAT067 PK of Atazanavir/Cobicistat and Darunavir/Cobicistat |
|
|
Interventional | Phase 1 |
|
Other / Industry |
|
|
16 | All | 18 Years to 65 Years (Adult) | NCT02589158 | SSAT067 | November 2015 | March 2016 | March 2016 | October 28, 2015 | March 22, 2016 |
|
||
28 | NCT02187107 | Completed | A Study to Assess the Long-term Safety and Tolerability of TMC114/Rtv in HIV-1 Infected Participants After Rolling-over From Other TMC114 Trials |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
52 | All | 18 Years and older (Adult, Senior) | NCT02187107 | CR005848 TMC114-C208 |
January 2005 | September 2005 | March 2009 | July 10, 2014 | August 25, 2014 |
|
||
29 | NCT01258439 | Completed | Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART. |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT01258439 | ROaR+ | ROaR+ | November 2010 | July 2014 | July 2014 | December 13, 2010 | January 12, 2015 |
|
|
30 | NCT01374802 | Completed Has Results |
Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
14 | All | 18 Years to 55 Years (Adult) | NCT01374802 | 1220.49 2011-000505-41 |
June 2011 | July 2011 | June 16, 2011 | July 31, 2015 | July 31, 2015 |
|
||
31 | NCT02155101 | Completed | Efficacy and Safety Study of Darunavir for the Treatment of HIV/AIDS |
|
|
Interventional | Phase 3 |
|
Other / Industry |
|
|
121 | All | 21 Years to 70 Years (Adult, Senior) | NCT02155101 | ChantalIRCB | MANET | May 2014 | June 2016 | July 2016 | June 4, 2014 | June 2, 2017 |
|
|
32 | NCT03017872 | Recruiting | Dolutegravir and Darunavir Evaluation in Adults Failing Therapy |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
610 | All | 18 Years and older (Adult, Senior) | NCT03017872 | D2EFT | D²EFT | November 1, 2017 | September 30, 2019 | December 30, 2020 | January 11, 2017 | January 12, 2018 |
|
|
33 | NCT01066962 | Completed | Study of Darunavir/r + Tenofovir/Emtricitabine vs. Darunavir/r + Raltegravir in HIV-infected Antiretroviral naïve Subjects |
|
|
Interventional | Phase 3 |
|
Other |
|
|
800 | All | 18 Years and older (Adult, Senior) | NCT01066962 | 2009-015113-44 | ANRS 143 | August 2010 | October 2013 | October 2013 | February 10, 2010 | November 6, 2013 |
|
|
34 | NCT01346982 | Completed | Drug Interactions Between Silimarine and Darunavir/Ritonavir |
|
|
Interventional | Phase 4 |
|
Other |
|
|
15 | All | 18 Years and older (Adult, Senior) | NCT01346982 | SILIDAR 2010-021159-25 |
March 2011 | July 2011 | July 2011 | May 4, 2011 | September 30, 2011 |
|
||
35 | NCT01726348 | Withdrawn | A Study to Assess the Safety and Effectiveness of Darunavir for Treating Human Immunodeficiency Virus-Type I (HIV-1) Infection in Filipino Patients |
|
|
Observational |
|
Industry |
|
|
0 | All | 18 Years and older (Adult, Senior) | NCT01726348 | CR014686 TMC114HIV4013 PRE-PHL-MA1 TMC-C-07-PH-007 |
January 2014 | December 2014 | December 2014 | November 14, 2012 | December 2, 2015 | ||||
36 | NCT00611039 | Completed | Evaluate the Efficacy and Security of Darunavir/Ritonavir 900/100 mg Once a Day as an Antiretroviral Treatment Simplification Strategy |
|
|
Interventional | Phase 4 |
|
Other |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT00611039 | DRV 900100 QD | DRV900100QD | February 2008 | July 2009 | July 2009 | February 8, 2008 | October 6, 2009 |
|
|
37 | NCT01928407 | Completed | Evaluation of the Efficacy and Safety Between Two Antiretroviral Regimens, in HIV-1-infected Treatment-naïve Subjects With Low CD4 Counts |
|
|
Interventional | Phase 4 |
|
Other |
|
|
120 | All | 18 Years and older (Adult, Senior) | NCT01928407 | IMEA 040-DATA | DATA | February 23, 2011 | March 29, 2011 | January 7, 2013 | August 26, 2013 | January 12, 2018 |
|
|
38 | NCT01258374 | Completed | Dual Therapy With Raltegravir and Darunavir/Ritonavir in HIV Infected Patients. |
|
|
Observational |
|
Other |
|
15 | All | 18 Years to 65 Years (Adult) | NCT01258374 | RALDAR-HCB | RALDAR | May 2010 | May 2011 | December 2011 | December 13, 2010 | September 2, 2015 |
|
|||
39 | NCT00855413 | Terminated Has Results |
HIV Viremia and Persistence in Acutely HIV-Infected Patients Treated With Darunavir/Ritonavir and Etravirine |
|
|
Interventional | Phase 4 |
|
Other / Industry |
|
|
15 | All | 18 Years and older (Adult, Senior) | NCT00855413 | CID 0821 | March 2009 | November 2013 | November 2013 | March 4, 2009 | October 17, 2017 | October 17, 2017 |
|
|
40 | NCT01073761 | Completed | Atazanavir/Ritonavir and Darunavir/Ritonavir PK Tail Study |
|
|
Interventional | Phase 1 |
|
Other |
|
|
25 | All | 18 Years to 65 Years (Adult) | NCT01073761 | SSAT 034 | April 2010 | June 2010 | June 2010 | February 23, 2010 | August 16, 2010 |
|
||
41 | NCT01391013 | Completed Has Results |
A Study to Compare Brachial Artery Reactivity and Cardiovascular Risk of a Treatment Simplification by Darunavir/Ritonavir (DRV/r) 800/100 mg Versus a Triple Combination Therapy Containing DRV/r in HIV-1 Infected Patients |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
30 | All | 18 Years and older (Adult, Senior) | NCT01391013 | CR017575 TMC114HIV3017 TMC-C-07-IT-016 |
MONARCH | June 2009 | April 2011 | April 2011 | July 11, 2011 | June 27, 2013 | June 27, 2013 | |
42 | NCT00993148 | Completed Has Results |
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 |
|
|
Interventional | Phase 2 |
|
Other / Industry |
|
|
25 | All | 18 Years and older (Adult, Senior) | NCT00993148 | MIDAS | MIDAS | May 2010 | April 2013 | April 2013 | October 12, 2009 | September 5, 2014 | August 19, 2014 |
|
43 | NCT00355524 | Completed | A Phase 2 Study to Evaluate Pharmacokinetics, Safety and Efficacy of TMC114/Ritonavir (Rtv) in Human Immunodeficiency Virus (HIV)-1 Infected Children and Adolescents |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
80 | All | 6 Years to 17 Years (Child) | NCT00355524 | CR002797 TMC114-C212 |
June 2006 | August 2007 | March 2011 | July 24, 2006 | July 8, 2013 |
|
||
44 | NCT00964327 | Completed | TMC114-C201: A Study to Determine the Antiviral Activity of TMC114 in Patients With Multiple Protease Inhibitor (PI) Resistant Human Immunodeficiency Virus (HIV) Strains |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
42 | All | 18 Years and older (Adult, Senior) | NCT00964327 | CR006718 | August 2001 | October 2003 | October 2003 | August 24, 2009 | May 19, 2011 | |||
45 | NCT00994344 | Completed | Clinical Study to Evaluate the Efficacy and Safety of Lopinavir/Ritonavir Monotherapy Versus Darunavir/Ritonavir Monotherapies as Simplification Switching Strategies of PI/NNRTI-Triple Therapy Based-Regimens |
|
|
Interventional | Phase 4 |
|
Other |
|
|
73 | All | 18 Years to 65 Years (Adult) | NCT00994344 | LOPIDAR | October 2009 | October 2012 | October 2012 | October 14, 2009 | February 13, 2014 |
|
||
46 | NCT01448707 | Completed Has Results |
A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
274 | All | 18 Years and older (Adult, Senior) | NCT01448707 | CR018370 TMC114IFD3003 2011-001635-23 PROTEA |
PROTEA | March 15, 2012 | June 11, 2014 | March 18, 2015 | October 7, 2011 | November 27, 2017 | December 3, 2015 |
|
47 | NCT01615601 | Completed | An Observational Study to Evaluate Tolerability of PREZISTA or INTELENCE in HIV-1 Infected Patients |
|
|
Observational |
|
Industry |
|
|
77 | All | 18 Years to 75 Years (Adult, Senior) | NCT01615601 | CR018595 TMC114HIV4068 |
POISE | October 2011 | April 2013 | April 2013 | June 8, 2012 | May 22, 2014 |
|
||
48 | NCT00531557 | Completed | Double Protease Inhibitor to Darunavir Switch Study |
|
|
Interventional | Phase 4 |
|
Other |
|
|
12 | All | 18 Years and older (Adult, Senior) | NCT00531557 | SSAT022 | September 2007 | November 2008 | November 2008 | September 19, 2007 | August 16, 2010 |
|
||
49 | NCT00458302 | Completed Has Results |
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
256 | All | 18 Years and older (Adult, Senior) | NCT00458302 | CR013159 TMC114HIV3006 2006-006437-40 |
MONET | June 2007 | February 2009 | January 2011 | April 10, 2007 | December 19, 2012 | February 26, 2010 |
|
50 | NCT00421551 | Completed | Study Comparing Efficacy and Safety of Darunavir Boosted With Ritonavir to HART With 2 NRTI and Darunavir Boosted With Ritonavir in HIV-1 Infected Patients ANRS136 |
|
|
Interventional | Phase 3 |
|
Other / Industry |
|
|
225 | All | 18 Years and older (Adult, Senior) | NCT00421551 | 2006-005962-38 ANRS 136 MONOI |
March 2007 | June 2010 | February 2011 | January 12, 2007 | July 18, 2013 |
|
† Study has passed its completion date and status has not been verified in more than two years.